Physiologically based pharmacokinetic (PBPK) modelling of cabotegravir (CAB) to support design of microarray patches (MAPs) for the treatment of HIV positive children

PAGE 30 (2022) Abstr 10101
Eriksson J, Sjögren E, Pellowe M, Choy RKM, Mistilis J, Jarrahian C, Zehrung D, Vora LK, Volpe-Zanutto F, Tekko IA, Donnelly RF, Chenel M.
ConferenceInfectious diseasesPBPK/PBBM

Pharmetheus Affiliates

Portrait-of-Johanna-Eriksson_Pharmetheus
Consultant

Johanna Eriksson

See bio
Portrait-of-Erik-Sjogren_Pharmetheus-2
Principal Consultant, PBPK & PBBM Platform Scientific Lead

Erik Sjögren

See bio
Portrait-of-Moriah-Pellowe_Pharmetheus
Consultant

Moriah Pellowe

See bio
Portrait-of-Marylore-Chenel_Pharmetheus
Chief Research Officer

Marylore Chenel

See bio